CLMT.NASDAQCalumet, INC /DE

Form 4: Calumet Director Amy Schumacher Granted RSUs

Sentiment:

Insider Transaction Report


Calumet Director Amy Schumacher received a grant of 1,965 Restricted Stock Units on August 5, 2025.

Summary

  • Amy M. Schumacher, a Director of Calumet, Inc. (CLMT), was granted a total of 1,965 Restricted Stock Units (RSUs) on August 5, 2025.
  • Of these, 1,474 RSUs are 100% vested and will be settled upon the earlier of a specified date or her termination.
  • The remaining 491 RSUs will vest at 25% annually, beginning on July 1, 2026, and will also be settled upon the earlier of a specified date or her termination, pursuant to the Deferred Compensation Plan.
  • Each RSU is economically equivalent to one share of Calumet, Inc. common stock, par value $0.01 per share.
  • The ownership form for these securities is direct.

Sentiment

Score: 7

Explanation: This Form 4 reports a routine equity compensation grant to a director, which is a standard practice for aligning interests and does not indicate any significant positive or negative operational or financial developments for the company.

Positives

  • The grant of Restricted Stock Units to Director Amy M. Schumacher aligns her interests with those of shareholders, promoting long-term value creation.
  • The vesting schedule for a portion of the RSUs encourages continued commitment and retention of key board members.

Negatives

  • No specific negative information is disclosed in this routine insider transaction report.

Risks

  • This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

A portion of the granted Restricted Stock Units (491 units) will vest annually starting July 1, 2026, indicating future equity compensation events. All RSUs will be settled upon the earlier of a specified date or the reporting person's termination.

Industry Context

The grant of Restricted Stock Units to a director is a common and widely accepted practice in publicly traded companies across various industries. This form of equity compensation is used to attract, retain, and incentivize board members by aligning their financial interests with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

  • Granting equity compensation, such as Restricted Stock Units, to non-employee directors is a standard practice in corporate governance across most industries.
  • While specific comparable companies or projects are not detailed in this filing, this compensation method is consistent with practices observed in companies of similar size and market capitalization, aiming to align director incentives with shareholder value.

Related Party Transactions

  • The grant of Restricted Stock Units to Amy M. Schumacher, a Director, constitutes a related party transaction as it involves compensation from the company to a member of its board. This is a standard compensation event.

Stakeholder Impact

  • Shareholders: The grant aligns the director's interests with shareholders, potentially fostering better long-term decision-making. It also represents a minor potential future dilution upon settlement of the RSUs.
  • Employees: No direct impact on general employees is indicated by this director-specific compensation filing.

Next Steps

  • Future vesting of 491 Restricted Stock Units, with 25% vesting annually starting July 1, 2026.
  • Settlement of all granted Restricted Stock Units upon the earlier of a specified date or the reporting person's termination.

Key Dates

DateDescription
08/05/2025Date of earliest transaction, representing the grant of Restricted Stock Units to Amy M. Schumacher.
07/01/2026First vesting date for 25% of the 491 Restricted Stock Units granted to Amy M. Schumacher.
08/07/2025Date the Form 4 filing was signed by the attorney-in-fact.

Keywords

Calumet, CLMT, Amy Schumacher, Restricted Stock Units, RSU, Director Compensation, Insider Trading, SEC Form 4, Equity Grant, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.